Randomized Study of Early Intravenous Esmolol Versus Oral Beta-Blockers in Preventing Post-CABG Atrial Fibrillation in High Risk Patients Identified by Signal-Averaged ECG: Results of a Pilot Study-Reference-Cited by-同舟云学术

Randomized Study of Early Intravenous Esmolol Versus Oral Beta-Blockers in Preventing Post-CABG Atrial Fibrillation in High Risk Patients Identified by Signal-Averaged ECG: Results of a Pilot Study

Published:2002-04 Issue:2 Volume:7 Page:86-91
ISSN:1082-720X
Container-title:Annals of Noninvasive Electrocardiology
language:en
Short-container-title:Ann Noninv Electrocard

Author:

Balcetyte-Harris Nomeda,Tamis Jacqueline E.,Homel Peter,Menchavez Edith,Steinberg Jonathan S.

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1542-474X.2002.tb00147.x/fullpdf

Reference15 articles.

1. Incidence, Timing and Outcome of Atrial Tachyarrhythmias After Cardiac Surgery

2. The Impact of Atrial Fibrillation on Hospital Length of Stay After Cardiac Surgery

3. Risk Factors for the Development of Postoperative Atrial Fibrillation

4. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery.

5. Signal averaged P wave compared with standard electrocardiography or echocardiography for prediction of atrial fibrillation after coronary bypass grafting.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Atrial Fibrillation After Cardiac Surgery;Cardiology in Review;2022-12-20

2. Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol;Clinical Pharmacology in Drug Development;2021-10-16

3. Does the Temporary Right Atrial Overdrive Pacing Enhance an Effect on Landiolol to Prevent Atrial Fibrillation after Off-pump Coronary Artery Bypass Grafting?;Journal of Coronary Artery Disease;2021

4. Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol;Cureus;2020-12-22

5. Ultraschnell wirksame Betablocker Esmolol und Landiolol: Aktuelle Rolle in der Intensiv- und Notfallmedizin;DMW - Deutsche Medizinische Wochenschrift;2019-09